STATE OF WISCONSIN INVESTMENT BOARD - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$924,783
-60.2%
44,936
-9.0%
0.00%
-57.1%
Q2 2023$2,322,130
+12.1%
49,386
-0.0%
0.01%
+16.7%
Q1 2023$2,072,320
+1.2%
49,388
-8.0%
0.01%
-14.3%
Q4 2022$2,046,936
-2.9%
53,669
-0.3%
0.01%0.0%
Q3 2022$2,107,000
+13.6%
53,808
-6.3%
0.01%
+40.0%
Q2 2022$1,854,000
+17.5%
57,413
+20.4%
0.01%
+66.7%
Q1 2022$1,578,000
+493.2%
47,675
+663.2%
0.00%
+200.0%
Q4 2021$266,000
-6.7%
6,247
-3.0%
0.00%0.0%
Q3 2021$285,000
-18.3%
6,440
+5.0%
0.00%0.0%
Q2 2021$349,000
-28.2%
6,136
-5.5%
0.00%0.0%
Q1 2021$486,000
-14.7%
6,490
-1.4%
0.00%0.0%
Q4 2020$570,000
+36.0%
6,584
-3.9%
0.00%0.0%
Q3 2020$419,000
+48.6%
6,854
+0.9%
0.00%0.0%
Q2 2020$282,000
+39.6%
6,794
-3.4%
0.00%0.0%
Q1 2020$202,000
-91.0%
7,034
-77.4%
0.00%
-83.3%
Q4 2019$2,246,000
+124.2%
31,106
+335.4%
0.01%
+100.0%
Q3 2019$1,002,000
-24.0%
7,144
-0.8%
0.00%
-25.0%
Q2 2019$1,318,000
-9.1%
7,198
-21.0%
0.00%0.0%
Q1 2019$1,450,000
+73.7%
9,115
+4.6%
0.00%
+33.3%
Q4 2018$835,000
-32.2%
8,7150.0%0.00%0.0%
Q3 2018$1,231,000
-11.7%
8,715
-2.2%
0.00%
-25.0%
Q2 2018$1,394,000
-79.9%
8,908
-79.3%
0.00%
-80.0%
Q1 2018$6,926,000
+10.7%
43,000
+13.2%
0.02%
+17.6%
Q4 2017$6,259,000
+201.3%
38,000
+14.0%
0.02%
+183.3%
Q3 2017$2,077,000
+4.3%
33,334
+33.3%
0.01%0.0%
Q2 2017$1,991,00025,0000.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders